Speech-Language Pathologists in Export, PA Accepting Medicare
7 Speech-Language Pathologists found. Showing 1 - 7
 Mrs. Jaclyn Bridges Jarvie, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1050 Corporate Ln Ste H, Export, PA 15632 Phone: 412-223-6876 |
Mrs. Tara Hogan Polons Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5916 Graybrooke Drive, Export, PA 15632 Phone: 412-980-6202 |
Jill L. Ellson, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3685 Wiestertown Rd, Export, PA 15632 Phone: 724-493-8189 |
Carrie Mason, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1050 Corporate Ln Ste H, Export, PA 15632 Phone: 412-223-6876 |
 Flourish Therapy, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6335 William Penn Hwy Ste 1000, Export, PA 15632 Phone: 412-223-6876 |
Diane Elizabeth Smith, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2396 Willow Dr, Export, PA 15632 Phone: 724-961-2054 |
Kaylee Marie Dougherty, MS,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6335 William Penn Hwy Ste 1000, Export, PA 15632 Phone: 412-223-6876 |
News Archive
No to over the counter statin!
Last Friday an FDA expert panel voted overwhelmingly against the over-the-counter sale of Merck's cholesterol lowering drug Mevacor (lovastatin). Mevacor is one of a number of drugs known as "statins" which are widely considered to be the most effective drugs for the treatment of high cholesterol. Statins work by inhibiting a liver enzyme used in the manufacture of cholesterol.
UK study finds link between low vitamin D status and non-alcoholic fatty liver disease in British children
A UK study investigating the link between low vitamin D status and non-alcoholic fatty liver disease (NAFLD) in British children has identified a genetic variant associated with the disease's severity.
LRI and lupus organizations congratulate HGS and GlaxoSmithKline for achieving historical landmark
The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for achieving an historical landmark - the second positive phase 3 clinical trial of Benlysta (belimumab), the first successfully tested new drug developed specifically for people with systemic lupus.
Looking into our bodies with state-of-the-art equipment
The University of Bristol is already world-famous for its biomedical research, but following a £2.3 million investment in newly refurbished labs, it will be able to advance techniques that look in even greater detail at what's going on in our bodies.
› Verified 7 days ago
Chiropractors
Speech-Language Pathologists
Physical Therapists
Occupational Therapists